# Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting

> **NCT01838057** · — · TERMINATED · sponsor: **Pfizer** · enrollment: 103 (actual)

## Conditions studied

- Low Back Pain

## Interventions

- **DEVICE:** painPREMIER cohort
- **OTHER:** Control cohort

## Key facts

- **NCT ID:** NCT01838057
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 103 (ACTUAL)
- **Why stopped:** The study was terminated on 02-Jun-2014 due to slow enrollment. The study was not terminated for reasons of either safety or efficacy.
- **Last updated:** 2015-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838057, "Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01838057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*